The estimated Net Worth of Roger D O'brien is at least $50.9 Thousand dollars as of 16 March 2021. Mr. brien owns over 52,400 units of 22nd Century Inc stock worth over $50,899 and over the last 5 years he sold XXII stock worth over $0. In addition, he makes $0 as Independent Director at 22nd Century Inc.
Roger has made over 1 trades of the 22nd Century Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 52,400 units of XXII stock worth $149,864 on 16 March 2021.
The largest trade he's ever made was buying 52,400 units of 22nd Century Inc stock on 16 March 2021 worth over $149,864. On average, Roger trades about 13,100 units every 0 days since 2020. As of 16 March 2021 he still owns at least 179,223 units of 22nd Century Inc stock.
You can see the complete history of Mr. brien stock trades at the bottom of the page.
Roger D. O'Brien serves as Independent Director of the Company. He has served as a director since his appointment on January 10, 2020 by the Board to fill a vacancy in the Class II director position resulting from the death of Dr. Joseph A. Dunn on November 30, 2019. Mr. O’Brien has served since 2000 as the President of O’Brien Associates, LLC, a general management consulting firm providing advisory and implementation services to companies in a variety of competitive industries, with special focus on general management, technology commercialization, marketing and strategy development. From 1998 to 1999, Mr. O’Brien served as the Chief Operating Officer of Ultralife Batteries, Inc. (Nasdaq: ULBI) and from 1991 to 1996, he was the Chief Executive Officer and a major shareholder of Holotek Ltd., a high-technology company with a proprietary position in the design, development, manufacture and sales of laser imaging systems worldwide. Previously, Mr. O’Brien served as a senior executive for Exxon Venture Capital, Tenneco Automotive and as an early officer of Sun Microsystems (Nasdaq: SUN) prior to the company’s acquisition by Oracle Corporation. Mr. O’Brien is currently a member of the Board of Directors of Innovative Technology Solutions and Bristol-ID Technologies, Inc. In addition, Mr. O’Brien is an adjunct professor at the Rochester Institute of Technology, where he is a graduate instructor in Rochester, New York and in Croatia. Mr. O’Brien holds a Bachelor of Science degree in Nuclear Engineering from New York University and an MBA degree from The Wharton School of the University of Pennsylvania. Mr. O’Brien’s experience with strategic advisory consulting and his prior public company experience led to our conclusion that he should serve as a director.
Roger Brien is 71, he's been the Independent Director of 22nd Century Inc since 2020. There are no older and 12 younger executives at 22nd Century Inc.
Roger's mailing address filed with the SEC is C/O 22ND CENTURY GROUP, INC., 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE, NY, 14221.
Over the last 11 years, insiders at 22nd Century Inc have traded over $3,035,006 worth of 22nd Century Inc stock and bought 652,225 units worth $737,196 . The most active insiders traders include Andrew Arno, Joseph Pandolfino, and Michael Zercher. On average, 22nd Century Inc executives and independent directors trade stock every 80 days with the average trade being worth of $16,372. The most recent stock trade was executed by Lawrence Firestone on 30 May 2024, trading 9,000 units of XXII stock currently worth $9,810.
with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.
22nd Century Inc executives and other stock owners filed with the SEC include: